890 results on '"Beuers U."'
Search Results
2. Aminotransferases During Treatment Predict Long-Term Survival in Patients With Autoimmune Hepatitis Type 1: A Landmark Analysis
3. The effects of laparoscopic Roux-en-Y gastric bypass and one-anastomosis gastric bypass on glycemic control and remission of type 2 diabetes mellitus: study protocol for a multi-center randomized controlled trial (the DIABAR-trial)
4. Association Between Black Race and Presentation and Liver-Related Outcomes of Patients With Autoimmune Hepatitis
5. Serum autoantibodies against annexin A11 might weaken the biliary bicarbonate umbrella in IgG4-related cholangitis
6. Autoimmunassoziierte Gallenwegserkrankungen: Diagnostische und therapeutische Herausforderungen
7. P301 Step-wise introduction of elexacaftor/tezacaftor/ivacaftor in patients with cystic fibrosis and liver cirrhosis Child-Pugh A or B using clinical- and therapeutic drug monitoring: a case series
8. Disease burden and management of Crigler-Najjar syndrome: Report of a world registry
9. IgG4-assoziierte Cholangitis – klinische Präsentation eines lange übersehenen Krankheitsbildes
10. Primär biliäre Cholangitis: Geänderter Name, neues Glück?
11. Modern work-up and extended resection in perihilar cholangiocarcinoma: the AMC experience
12. Incidence and predictors of hepatocellular carcinoma in autoimmune hepatitis: A multicenter international study
13. Disease burden in primary sclerosing cholangitis in the Netherlands: A long-term follow-up study.
14. Autoimmune Pancreatitis in Europe: Clinical Profile and Response to Treatment
15. Chronische cholestatische Leberkrankheiten: Differenzialdiagnose, Pathogenese und aktuelle Therapie beim Erwachsenen
16. Disease burden in primary sclerosing cholangitis in the Netherlands
17. Aminotransferases During Treatment Predict Long-Term Survival in Patients With Autoimmune Hepatitis Type 1: A Landmark Analysis
18. 10 Cholestatische leverziekten
19. Erkrankungen der Gallenblase und der Gallenwege
20. Cholestatische Lebererkrankungen und Stoffwechselerkrankungen der Leber
21. Cholestatische Lebererkrankungen und Stoffwechselerkrankungen der Leber
22. The effects of laparoscopic Roux-en-Y gastric bypass and one-anastomosis gastric bypass on glycemic control and remission of type 2 diabetes mellitus:study protocol for a multi-center randomized controlled trial (the DIABAR-trial)
23. Therapy of primary sclerosing cholangitis
24. HLA-DRB1*03:01 and HLA-DRB1*04:01 modify the presentation and outcome in autoimmune hepatitis type-1
25. Additional file 1 of The effects of laparoscopic Roux-en-Y gastric bypass and one-anastomosis gastric bypass on glycemic control and remission of type 2 diabetes mellitus: study protocol for a multi-center randomized controlled trial (the DIABAR-trial)
26. The challenges of primary biliary cholangitis: What is new and what needs to be done
27. Association Between Black Race and Presentation and Liver-Related Outcomes of Patients With Autoimmune Hepatitis
28. European Guideline on IgG4-related digestive disease - UEG and SGF evidence-based recommendations
29. A Placebo-Controlled Trial of Obeticholic Acid in Primary Biliary Cholangitis
30. Development and validation of a prognostic score for long-term transplant-free survival in autoimmune hepatitis type 1
31. A placebo-controlled randomised trial of budesonide for primary biliary cholangitis following an insufficient response to UDCA
32. Unaltered liver regeneration in post‐cholestatic rats treated with the fxr agonist obeticholic acid
33. Cholestatischer Pruritus: Neues zur Pathophysiologie und aktuelle Therapie
34. Doppler follow-up after tips placement is not routinely indicated. A 16-years single centre experience
35. 44-jährige Patientin mit unklarer Leberwerterhöhung und familiär gehäuftem Gallensteinleiden
36. Fucosyltransferase-2 Non-Secretor Status Is Associated With Non-Anastomotic Biliary Strictures After Liver Transplantation in Recipients With Primary Sclerosing Cholangitis.: Abstract# A406
37. Primär biliäre Zirrhose: Neues zur Pathogenese und Therapie
38. Tauroursodeoxycholic acid exerts anticholestatic effects by a cooperative cPKC[alpha]-/PKA-dependent mechanism in rat liver
39. Non-alcoholic fatty liver disease: a multidisciplinary approach towards a cardiometabolic liver disease
40. Prevention of hepatic encephalopathy by administration of rifaximin and lactulose in patients with liver cirrhosis undergoing placement of a transjugular intrahepatic portosystemic shunt (TIPS): A multicentre randomised, double blind, placebo controlled trial (PEARL trial)
41. Lipids | Bile Salts
42. Bile Salts
43. Vergleich von 2D- und 3D-Sequenzen für die MRCP: Klinischer Stellenwert der einzelnen Techniken
44. Sulfasalazine reduces bile acid induced apoptosis in human hepatoma cells and perfused rat livers
45. Adaptive regulation of the ileal apical sodium dependent bile acid transporter (ASBT) in patients with obstructive cholestasis
46. Prevention of hepatic encephalopathy by administration of rifaximin and lactulose in patients with liver cirrhosis undergoing placement of a transjugular intrahepatic portosystemic shunt (TIPS): a multicentre randomised, double blind, placebo controlled trial (PEARL trial)
47. Neues zum cholestatischen Pruritus und dessen Therapie mit Rifampicin: AKS07/02
48. 31-jährige Patientin mit kolikartigen Oberbauchschmerzen und Eosinophilie
49. Die allogene Lebertransplantation – eine Form der „Gentherapie“ bei metabolischen Erkrankungen: Münchener Ergebnisse und Übersicht
50. Role of side-chain amidation for the anticholestatic action of nourursodeoxycholic acid in rat liver
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.